In the HNSCC cell line, UMSCC74B and O28, afatinib inhibited EGFR and PI3K/Akt signaling and simultaneously induced the MEK/MAPK part of RAS signaling. The gene discussed is MAP2K7; the disease is head and neck squamous cell carcinoma.